“New prostate cancer tests aim to reduce the death rate”

A new article with the above title (by Andrew Zaleski) on the CNBC web site gives background on some of the wide range of new tests that are starting to help to tell us who really needs early treatment for prostate cancer and who doesn’t. This article may be a useful backgrounder of many readers … but it doesn’t address all of these new tests …

Results of the PCaI prostate cancer patient “value” survey

Earlier this year, in late May and early June, Prostate Cancer International (PCaI) conducted what we have described as a very primitive pilot survey on prostate cancer patients’ perceptions of “value” in the management of this disease. … READ MORE …

Just how accurate are current genetic/genomic tests in the diagnosis and prognosis of prostate cancer?

As we have pointed out regularly over the years, all prostate cancers are by no means the same. And a recently published paper in European Urology makes the inherent diversity in the subtypes of prostate cancer even clearer — even within any one specific patient. … READ MORE …

PCA3, mpMRI, targeted biopsies, and risk for diagnosis of prostate cancer

The degree to which the PCA3 test is a useful tool in assessment of risk for clinically significant prostate cancer prior to biopsy has never, really, been entirely clear. … READ MORE …

Obesity and risk for diagnosis with prostate cancer

A new report from the International Agency Research on Cancer (IARC) Handbook Working Group has concluded that there is a definitive link between “body fatness”  and increased risk for diagnosis with 13 different types of cancer — but prostate cancer is not on that list. … READ MORE …

The impact of the USPSTF recommendation against screening: another take

A research letter from the epidemiologists and statisticians at the American Cancer Society has just been published in JAMA Oncology. The full text of the research letter is available on line. … READ MORE …

A new set of risk strata to define prognostic risk for men with localized prostate cancer

A newly published paper in the journal PLoS Medicine has set out a new set of definitions of five “risk strata” into which we can subdivide men diagnosed with prostate cancer. … READ MORE …